Saswata Talukdar
Reproducibility track record
1
assessed papers
—
mean reproducibility
0
reproduced (C1–C2)
0
flagged
0
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
—
Funders
—
Frequent co-authors
Christian Schlein 1Jöerg Heeren 1Stefan K. Nilsson 1Lucia M. Krott 1Ludger Scheja 1Alexander W. Fischer 1Markus Heine 1Martin Brenner 1
Institutions
Universität Hamburg 1University Medical Center Hamburg-Eppendorf 1Pfizer (United States) 1
Geography (author institutions)
DE 1US 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (70)
Request a reproduction →1 assessed by us (0 reproduced) · 69 not yet assessed — every PubMed paper on record, linked below.
-
CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assembly ↗Nature · 2026 · PMID 41741636not yet assessed
-
AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool ↗JHEP Reports · 2026 · PMID 41825098not yet assessed
-
LC-MS measurement of triglyceride hydrolysis: Application in studies of Patatin-like phospholipase domain-containing protein 3 activity ↗Analytical Biochemistry · 2026 · PMID 41839402not yet assessed
-
AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models ↗Nature Communications · 2026 · PMID 42486853not yet assessed
-
Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver disease ↗Hepatology Communications · 2025 · PMID 39927988not yet assessed
-
A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse models of chronic liver disease ↗Biochemical Journal · 2025 · PMID 41428769not yet assessed
-
Whole body and hematopoietic cell-specific deletion of G-protein coupled receptor 65 (GPR65) improves insulin sensitivity in diet-induced obese mice ↗Molecular Metabolism · 2025 · PMID 40389090not yet assessed
-
Lc-Ms Measurement of Triglyceride Hydrolysis: Application in Studies of Patatin-Like Phospholipase Domain-Containing Protein 3 Activity ↗SSRN Electronic Journal · 2025not yet assessed
-
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH ↗Journal of Hepatology · 2024 · PMID 39612947not yet assessed
-
CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assembly ↗bioRxiv (Cold Spring Harbor Laboratory) · 2024 · PMID 38895340not yet assessed
-
THU-198 In vitro and in vivo pharmacological characterization of human PNPLA3-targeting short interfering RNA molecules for the treatment of metabolic dysfunction-associated steatohepatitis ↗Journal of Hepatology · 2024not yet assessed
-
FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP ↗Angiogenesis · 2023 · PMID 36943533not yet assessed
-
Leukotriene B4 receptor 1 does not mediate disease progression in a mouse model of liver fibrosis ↗Biochemical Journal · 2023 · PMID 38014500not yet assessed
-
Supplementary Material for: Regulation of macrophage cell surface GAPDH alters LL-37 internalization and downstream effects in the cell ↗Figshare · 2023not yet assessed
-
Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity ↗Nutrients · 2022 · PMID 35405946not yet assessed
-
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies ↗SLAS DISCOVERY · 2022 · PMID 35058172not yet assessed
-
Loss of low-molecular-weight protein tyrosine phosphatase shows limited improvement in glucose tolerance but causes mild cardiac hypertrophy in mice ↗American Journal of Physiology-Endocrinology and Metabolism · 2022 · PMID 35403438not yet assessed
-
Discovery of a new class of integrin antibodies for fibrosis ↗Scientific Reports · 2021 · PMID 33483531not yet assessed
-
Müller glial responses compensate for degenerating photoreceptors in retinitis pigmentosa ↗Experimental & Molecular Medicine · 2021 · PMID 34799683not yet assessed
-
Retinal glial remodeling by FGF21 preserves retinal function during photoreceptor degeneration ↗iScience · 2021 · PMID 33937726not yet assessed
-
Vitreous metabolomics profiling of proliferative diabetic retinopathy ↗Diabetologia · 2020 · PMID 33099660not yet assessed
-
FGF19 and FGF21: In NASH we trust ↗Molecular Metabolism · 2020 · PMID 33383173not yet assessed
-
Positive Reinforcing Mechanisms between GPR120 and PPARγ Modulate Insulin Sensitivity ↗Cell Metabolism · 2020 · PMID 32413335not yet assessed
-
Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis ↗Cell Reports Medicine · 2020 · PMID 33205063not yet assessed
-
Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models ↗International Journal of Molecular Sciences · 2020 · PMID 32054022not yet assessed
-
Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction ↗Scientific Reports · 2020 · PMID 32099031not yet assessed
-
Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice ↗Angiogenesis · 2020 · PMID 32140799not yet assessed
-
Mapping Lipogenic Flux: A Gold LDI–MS Approach for Imaging Neutral Lipid Kinetics ↗Journal of the American Society for Mass Spectrometry · 2020 · PMID 32840373not yet assessed
-
GPR105 Ablation Prevents Inflammation and Improves Insulin Sensitivity in Mice with Diet-Induced Obesity ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020not yet assessed
-
Discovery of A New Class of Integrin Antibodies for Fibrosis ↗bioRxiv (Cold Spring Harbor Laboratory) · 2020not yet assessed
-
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease ↗Journal of Clinical Investigation · 2019 · PMID 31805015not yet assessed
-
Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice ↗Diabetes · 2018 · PMID 29487115not yet assessed
-
Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing ↗Scientific Reports · 2018 · PMID 29523796not yet assessed
-
FGF21 restores photoreceptor function in type 1 diabetic miceInvestigative Ophthalmology & Visual Science · 2018not yet assessed
-
Photoreceptor glucose metabolic modulation by adiponectin prevents hyperglycemic ROPInvestigative Ophthalmology & Visual Science · 2018not yet assessed
-
Once‐weekly administration of a long‐acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non‐human primates ↗Diabetes Obesity and Metabolism · 2017 · PMID 28573777not yet assessed
-
FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice ↗Cell Reports · 2017 · PMID 28199833not yet assessed
-
Photoreceptor glucose metabolism determines normal retinal vascular growth ↗EMBO Molecular Medicine · 2017 · PMID 29180355not yet assessed
-
FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis ↗Molecular Metabolism · 2017 · PMID 28580278not yet assessed
-
Fibroblast growth factor 21 administration suppresses pathologic retinal vessel growth in oxygen-induced retinopathyInvestigative Ophthalmology & Visual Science · 2017not yet assessed
-
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects ↗Cell Metabolism · 2016 · PMID 26959184not yet assessed
-
FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose TissuesCell Metabolism · 2016 · PMID 26853749L1 No computation
-
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates ↗Journal of Pharmacokinetics and Pharmacodynamics · 2016 · PMID 27405817not yet assessed
-
FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues ↗Atherosclerosis · 2016not yet assessed
-
FGF21 Regulates Sweet and Alcohol Preference ↗Cell Metabolism · 2015 · PMID 26724861not yet assessed
-
LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes ↗Nature Medicine · 2015 · PMID 25706874not yet assessed
-
Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice ↗PLoS ONE · 2015 · PMID 25790234not yet assessed
-
FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance ↗Scientific Reports · 2015 · PMID 26153793not yet assessed
-
Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes ↗PLoS ONE · 2014 · PMID 25365322not yet assessed
-
Knock-Down of IL-1Ra in Obese Mice Decreases Liver Inflammation and Improves Insulin Sensitivity ↗PLoS ONE · 2014 · PMID 25244011not yet assessed
-
NCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids ↗Cell · 2013 · PMID 24074869not yet assessed
-
Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody ↗Journal of Pharmacology and Experimental Therapeutics · 2013 · PMID 23720456not yet assessed
-
Neuronal Sirt1 Deficiency Increases Insulin Sensitivity in Both Brain and Peripheral Tissues ↗Journal of Biological Chemistry · 2013 · PMID 23457303not yet assessed
-
Correction: GPR105 Ablation Prevents Inflammation and Improves Insulin Sensitivity in Mice with Diet-Induced Obesity ↗The Journal of Immunology · 2013not yet assessed
-
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase ↗Nature Medicine · 2012 · PMID 22863787not yet assessed
-
Maintenance of Metabolic Homeostasis by Sestrin2 and Sestrin3 ↗Cell Metabolism · 2012 · PMID 22958918not yet assessed
-
GPR105 Ablation Prevents Inflammation and Improves Insulin Sensitivity in Mice with Diet-Induced Obesity ↗The Journal of Immunology · 2012 · PMID 22778393not yet assessed
-
G protein–coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice ↗Journal of Clinical Investigation · 2012 · PMID 22653059not yet assessed
-
Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet–Induced Insulin Resistance ↗Diabetes · 2011 · PMID 21911747not yet assessed
-
Increased Macrophage Migration Into Adipose Tissue in Obese Mice ↗Diabetes · 2011 · PMID 22190646not yet assessed
-
Adipocyte NCoR Knockout Decreases PPARγ Phosphorylation and Enhances PPARγ Activity and Insulin Sensitivity ↗Cell · 2011 · PMID 22078880not yet assessed
-
Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases ↗Trends in Pharmacological Sciences · 2011 · PMID 21663979not yet assessed
-
Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinediones ↗Nature Medicine · 2011 · PMID 21532596not yet assessed
-
Adipocyte NCoR Knockout Decreases PPARg Phosphorylation and Enhances PPARg Activity and Insulin Sensitivity2011not yet assessed
-
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects ↗Cell · 2010 · PMID 20813258not yet assessed
-
Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice ↗PLoS ONE · 2010 · PMID 21103061not yet assessed
-
The role of the ERK MAP kinase pathway in CD4 T cell proliferation and differentiation ↗The FASEB Journal · 2008not yet assessed
-
Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317 ↗Journal of Lipid Research · 2007 · PMID 17823458not yet assessed
-
The mechanism mediating the activation of acetyl-coenzyme A carboxylase-α gene transcription by the liver X receptor agonist T0-901317 ↗Journal of Lipid Research · 2006 · PMID 16931873not yet assessed
-
not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Talukdar S” paper on PubMed ↗